Dr. Tat Wa Yau, M.D., M.P.H. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 3952 Aspen Dr, Harvey, LA 70058 Phone: 504-722-1875 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has revealed new results from a global survey demonstrating that 66% of patients with metastatic colorectal cancer (mCRC) are now tested for KRAS to determine if they could benefit from a personalized therapy, such as Erbitux® (cetuximab). This represents a 50% increase in levels of KRAS testing in just one year.
Dispositional, or "everyday" mindfulness is the inherent trait of being aware of one's present thoughts and feelings. In a new study of 399 people that measured health indicators including dispositional mindfulness and blood glucose, researchers found that those with higher scores for mindfulness were significantly more likely than people with low scores to have healthy glucose levels.
Cognizant today announced it has acquired Cadient Group, a full-service digital marketing agency that serves a broad spectrum of life sciences companies in the pharmaceutical, biotechnology, consumer health, and medical device industries.
Nov. 1 marks the start of Open Enrollment for people buying their own coverage for 2019 in most states. Despite the turmoil surrounding the Affordable Care Act, most consumers will have more choices and mostly flat — and in some cases lower — premiums.
The Government of Rwanda, together with QIAGEN N.V. and Merck, known as MSD outside the United States and Canada, today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.
› Verified 9 days ago